Involvement of the myenteric plexus in the cholera toxin-induced net fluid secretion in the rat small intestine

1993 ◽  
Vol 105 (5) ◽  
pp. 1286-1293 ◽  
Author(s):  
Mats Jodal ◽  
Susanne Holmgren ◽  
Ove Lundgren ◽  
Anders Sjöqvist
1989 ◽  
Vol 24 (1) ◽  
pp. 1-8 ◽  
Author(s):  
D. D. K. Rolston ◽  
M. J. Kelly ◽  
M. M. Borodo ◽  
A. M. Dawson ◽  
M. J. G. Farthing

1978 ◽  
Vol 21 (2) ◽  
pp. 373-380 ◽  
Author(s):  
G W Forsyth ◽  
D L Hamilton ◽  
K E Goertz ◽  
M R Johnson

1996 ◽  
Vol 270 (6) ◽  
pp. G1001-G1009 ◽  
Author(s):  
B. A. Moore ◽  
K. A. Sharkey ◽  
M. Mantle

We examined the role of 5-hydroxytryptamine (5-HT) in cholera toxin (CT)-induced mucin secretion in the proximal and distal regions of the rat small intestine. Neither the 5-HT2 receptor antagonist ketanserin nor the cyclooxygenase inhibitor indomethacin was capable of inhibiting choleraic mucin secretion. However, in the presence of the mixed 5-HT3/4 receptor antagonist tropisetron at doses that block both receptor subtypes, the secretory response was reduced to baseline levels in the proximal and distal small intestine. The selective 5-HT3 receptor antagonist ondansetron had no significant effect. These findings suggest that choleraic mucin secretion is mediated primarily through the activation of a 5-HT4-like receptor. Mucin secretion in response to the exogenous application of 5-HT occurs via two pathways: one is mediated by a 5-HT4-like receptor and is capsaicin sensitive but tetrodotoxin (TTX) insensitive, and one lacks the capsaicin-sensitive 5-HT4-mediated response but is TTX sensitive. Both converge on a common pathway that is cholinergic. No significant differences were observed between proximal and distal intestinal segments.


Gut ◽  
1996 ◽  
Vol 38 (6) ◽  
pp. 853-858 ◽  
Author(s):  
I R Sanderson ◽  
Z Xu ◽  
S W Chu ◽  
Q Y Xie ◽  
L J Levine ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document